Advanced Medical Solutions Group on Monday said it has gotten approval from the U.S. Food and Drug Administration for the use of its wound closure device LiquiBandFix8 in hernia surgery.
The U.K. surgical and woundcare specialist said the approval covers its device for use in open surgery as well as one for laparoscopic use.
LiquiBandFix8 was also approved for use in closing the membrane surrounding the abdominal cavity, it added.
The device, which is already being commercialized in Europe and other non-U.S. markets, is expected to launch commercially in the U.S. in the second half of 2023, it said, adding it is in late stage negotiations with a number of potential partners.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.